DE69816284D1 - Azol-verbindungen, ihre herstellung und ihre verwendung - Google Patents

Azol-verbindungen, ihre herstellung und ihre verwendung

Info

Publication number
DE69816284D1
DE69816284D1 DE69816284T DE69816284T DE69816284D1 DE 69816284 D1 DE69816284 D1 DE 69816284D1 DE 69816284 T DE69816284 T DE 69816284T DE 69816284 T DE69816284 T DE 69816284T DE 69816284 D1 DE69816284 D1 DE 69816284D1
Authority
DE
Germany
Prior art keywords
production
vivo
eliminated
quaternized
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69816284T
Other languages
English (en)
Other versions
DE69816284T2 (de
Inventor
Katsumi Itoh
Tomoyuki Kitazaki
Kenji Okonogi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of DE69816284D1 publication Critical patent/DE69816284D1/de
Publication of DE69816284T2 publication Critical patent/DE69816284T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Coloring (AREA)
DE69816284T 1997-03-31 1998-03-30 Azol-verbindungen, ihre herstellung und ihre verwendung Expired - Fee Related DE69816284T2 (de)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
JP8086397 1997-03-31
JP8086397 1997-03-31
JP18239597 1997-07-08
JP18239597 1997-07-08
JP33729997 1997-12-08
JP33729997 1997-12-08
PCT/JP1998/001441 WO1998043970A1 (en) 1997-03-31 1998-03-30 Azole compounds, their production and their use

Publications (2)

Publication Number Publication Date
DE69816284D1 true DE69816284D1 (de) 2003-08-14
DE69816284T2 DE69816284T2 (de) 2004-05-27

Family

ID=27303408

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69816284T Expired - Fee Related DE69816284T2 (de) 1997-03-31 1998-03-30 Azol-verbindungen, ihre herstellung und ihre verwendung

Country Status (11)

Country Link
US (1) US6407129B1 (de)
EP (1) EP0973768B1 (de)
JP (1) JP2000198773A (de)
KR (1) KR20010005792A (de)
CN (1) CN1251098A (de)
AT (1) ATE244715T1 (de)
AU (1) AU6520098A (de)
CA (1) CA2281875A1 (de)
DE (1) DE69816284T2 (de)
RU (1) RU2189982C2 (de)
WO (1) WO1998043970A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19751525C2 (de) 1997-11-20 2003-02-13 Bat Cigarettenfab Gmbh Verfahren und Vorrichtung zur Regelung der Ausgangsfeuchte von Tabak
AU5760999A (en) * 1998-09-29 2000-04-17 Takeda Chemical Industries Ltd. Antimycotic drug composition
WO2000030655A1 (en) 1998-11-20 2000-06-02 Bristol-Myers Squibb Company Water soluble prodrugs of azole compounds
US6235728B1 (en) 1999-02-19 2001-05-22 Bristol-Myers Squibb Company Water-soluble prodrugs of azole compounds
AU777859B2 (en) * 1999-11-02 2004-11-04 Basilea Pharmaceutica International Ag, Allschwil N-substituted carbamoyloxyalkyl-azolium derivatives
US6812238B1 (en) 1999-11-02 2004-11-02 Basilea Pharmaceutica Ag N-substituted carbamoyloxyalkyl-azolium derivatives
US6376548B1 (en) 2000-01-28 2002-04-23 Rohm And Haas Company Enhanced propertied pesticides
US20050159369A1 (en) * 2003-08-20 2005-07-21 Qtm Llc Method of treatment of otitis externa
US20070078116A1 (en) * 2003-08-20 2007-04-05 Fairfield Clinical Trials, Llc Method of treatment of otitis externa
JP4101852B2 (ja) 2004-05-26 2008-06-18 エーザイ・アール・アンド・ディー・マネジメント株式会社 シンナミド化合物
CA2580119A1 (en) 2004-10-26 2006-05-04 Eisai R & D Management Co., Ltd. Amorphous object of cinnamide compound
TWI370130B (en) 2005-11-24 2012-08-11 Eisai R&D Man Co Ltd Two cyclic cinnamide compound
KR20080069221A (ko) 2005-11-24 2008-07-25 에자이 알앤드디 매니지먼트 가부시키가이샤 모르폴린 타입의 신나미드 화합물
TWI378091B (en) 2006-03-09 2012-12-01 Eisai R&D Man Co Ltd Multi-cyclic cinnamide derivatives
US7737141B2 (en) 2006-07-28 2010-06-15 Eisai R&D Management Co., Ltd. Prodrug of cinnamide compound
CL2008000582A1 (es) 2007-02-28 2008-06-27 Eisai R&D Man Co Ltd Compuestos ciclicos derivados de oximorfolina condensados; farmacos que comprenden a dichos compuestos; y su uso para tratar enfermedad de alzheimer, demencia senil, sindrome de down o amiloidosis.
EP1990617A1 (de) * 2007-05-09 2008-11-12 FOSS Analytical A/S Bestimmung von Tanninen in der Weinherstellung
TW200916469A (en) 2007-08-31 2009-04-16 Eisai R & Amp D Man Co Ltd Multi-cyclic compounds
US7935815B2 (en) 2007-08-31 2011-05-03 Eisai R&D Management Co., Ltd. Imidazoyl pyridine compounds and salts thereof
JP5453093B2 (ja) * 2007-09-05 2014-03-26 株式会社ポーラファルマ 抗真菌医薬組成物
US11225463B2 (en) 2016-11-28 2022-01-18 Cellix Bio Private Limited Compositions and methods for the treatment of oral infectious diseases
IL287622B (en) * 2016-11-28 2022-07-01 Cellix Bio Private Ltd Preparations and methods for treating fungal infections
EP3584245A4 (de) * 2017-02-17 2020-08-26 Wuhan LL Science And Technology Development Co., Ltd. Antibakterielles derivat aus triazol sowie pharmazeutische zusammensetzung und verwendung davon
US20200138964A1 (en) * 2017-04-25 2020-05-07 Seikagaku Corporation Tertiary amine compound or imine compound-polymer conjugate and production method therefor

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3998815A (en) 1974-06-24 1976-12-21 Interx Research Corporation 1-hydrocarbonoyloxymethyl-3-carbamoyl or 3-carboethoxy-pyridinium salts
US4061722A (en) * 1976-04-26 1977-12-06 Interx Research Corporation Selected quaternary ammonium salts of pilocarpine useful in reducing intraocular pressure in warm-blooded animals
EP0548553A1 (de) 1991-11-25 1993-06-30 Takeda Chemical Industries, Ltd. Optisch aktive Azolverbindungen, ihre Herstellung und Anwendung
TW218017B (de) * 1992-04-28 1993-12-21 Takeda Pharm Industry Co Ltd
JPH08104676A (ja) * 1993-09-24 1996-04-23 Takeda Chem Ind Ltd アゾール化合物、その製造方法及び用途
TW297813B (de) * 1993-09-24 1997-02-11 Takeda Pharm Industry Co Ltd
TW318841B (de) * 1995-02-17 1997-11-01 Takeda Pharm Industry Co Ltd
AU4675596A (en) * 1995-02-17 1996-09-04 Takeda Chemical Industries Ltd. Azole compounds, their production and use
EP0829478A3 (de) 1996-09-09 1998-03-25 F. Hoffmann-La Roche Ag N-Benzylimidazolium und N-Benzyltriazolium Derivate, deren Herstellung und deren Verwendung als fungizides und anti-mykotisches Mittel

Also Published As

Publication number Publication date
US6407129B1 (en) 2002-06-18
ATE244715T1 (de) 2003-07-15
DE69816284T2 (de) 2004-05-27
CA2281875A1 (en) 1998-10-08
EP0973768A1 (de) 2000-01-26
CN1251098A (zh) 2000-04-19
EP0973768B1 (de) 2003-07-09
JP2000198773A (ja) 2000-07-18
WO1998043970A1 (en) 1998-10-08
RU2189982C2 (ru) 2002-09-27
KR20010005792A (ko) 2001-01-15
AU6520098A (en) 1998-10-22

Similar Documents

Publication Publication Date Title
DE69816284D1 (de) Azol-verbindungen, ihre herstellung und ihre verwendung
TR199802693T2 (xx) De�i�tirilmi� 3,5-difenil-1,2,4-triazoller ve eczasal metal kelatorlar olarak kullan�m�.
DE69329727D1 (de) Neue imidazol derivate, ihre herstellung und therapeutische verwendung
DE60044395D1 (de) Arylsubstituierte pyrazole, imidazole, oxazole, thiazole und pyrrole, sowie deren verwendung
WO2001038324A3 (en) Imidazole derivatives and their use as raf kinase inhibitors
TR199801350T2 (xx) Yeni sikloalkil ikameli imidazoller.
BG101112A (en) The use of heterocyclic compounds
WO1998028282A3 (en) OXYGEN OR SULFUR CONTAINING 5-MEMBERED HETEROAROMATICS AS FACTOR Xa INHIBITORS
TR199801360T2 (xx) Yeni ikameli imidazol bile�imleri.
DE60012188D1 (de) Fungizide
AU1676200A (en) Polyhydroxylated heterocyclic derivatives as anti-coagulants
ZA908301B (en) Use of substituted imidazolas
EP0834253A3 (de) Antimikrobielle Zusammensetzung.
BG105840A (en) Heterocyclic benzenesulphonamide compounds as bradykinine antagonists
WO2000061585A3 (en) 1,3-dipolar cycloadditions to polypyrrolic macrocycles
PT1157030E (pt) Complexos equinocandina/hidrato de carbono
AR045991A2 (es) Compuesto de urea
MY103241A (en) Imidazole and 1,2,4 triazole derivatives
KR970707108A (ko) 항염증제로 유용한, 복소환부를 갖는 디-t-부틸페놀 화합물(DI-TERT-BUTYLPHENOL COMPOUNDS WITH HETEROCYCLIC MOIETY, USEFUL AS ANTI-INFLAMMATORY AGENTS)
ATE219623T1 (de) Antimikrobielle lösungen
TR200002242T2 (tr) 5-(2-İmidazolinilamino)-benzimidazol türevleri, bunların hazırlanması ve metabolik kararlılığı gelişmiş alfa-adrenoseptör agonistleri olarak kullanımları.
TR199802033T2 (xx) Böcek öldürücü siprodinil ve miklobutanil bileşimi.
AP1567A (en) Echinocandin derivatives, preparation method and application as anti-fungal agents.
IT1296924B1 (it) Composti diolici intermedi per la preparazione di composti ad attivita' antimicotica
TR200001941T1 (tr) TNF ve PDE-IV önleyici aktiviteye sahip heterosiklik bileşiklerin N-oksitleri.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: TAKEDA PHARMACEUTICAL CO. LTD., OSAKA, JP

8339 Ceased/non-payment of the annual fee